139 related articles for article (PubMed ID: 7511284)
1. [Value of cytometric parameters the planning of therapy of urothelial carcinoma].
Taubert G; Rassler J; Nenning H; Rose S
Verh Dtsch Ges Pathol; 1993; 77():216-21. PubMed ID: 7511284
[TBL] [Abstract][Full Text] [Related]
2. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
3. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
Fossä SD
Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
[TBL] [Abstract][Full Text] [Related]
4. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
Maier G; Heissler HE; Blech M; Schröter W
Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
[TBL] [Abstract][Full Text] [Related]
5. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
6. [Transitional carcinoma of the bladder. Evaluation of prognostic factors].
Fodor M; Alonso E; Bellotti M; Elsner B; Aparisi I; Pisilli L
Medicina (B Aires); 1993; 53(5):413-8. PubMed ID: 7646600
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
[TBL] [Abstract][Full Text] [Related]
10. DNA-variations in neighbouring epithelium in patients with bladder carcinoma.
Foss SD
Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):603-10. PubMed ID: 920179
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
Bittard H; Lamy B; Billery C
J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
[TBL] [Abstract][Full Text] [Related]
12. DNA slit-scan flow cytometry of bladder irrigation specimens and the importance of recognizing urothelial cells.
Wheeless LL; Reeder JE; O'Connell MJ; Robinson RD; Cosgriff JM; Fradet Y; Frank IN; Cockett AT
Cytometry; 1991; 12(2):140-6. PubMed ID: 2049971
[TBL] [Abstract][Full Text] [Related]
13. DNA-malignancy-grading of bladder tumor and its clinical significance.
Wang XZ; Ma YJ; Zheng JF; Qin HY
Chin Med J (Engl); 1992 Oct; 105(10):856-9. PubMed ID: 1291205
[TBL] [Abstract][Full Text] [Related]
14. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma.
Kamel MH; Daly PJ; Khan MF; Kay EW; O'Kelly P; Hickey DP
Eur J Surg Oncol; 2006 Dec; 32(10):1139-43. PubMed ID: 16784833
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
17. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
18. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
Raitanen MP; Tammela TL
Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
